Roger D. Dansey - 13 May 2023 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Director
Signature
/s/ Roger Dansey
Issuer symbol
INO
Transactions as of
13 May 2023
Net transactions value
$0
Form type
4
Filing time
16 May 2023, 16:48:47 UTC
Previous filing
24 Apr 2023
Next filing
26 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +12,000 +100% 24,000 13 May 2023 Direct F1
transaction INO Common Stock Options Exercise +19,000 +79% 43,000 16 May 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Options Exercise $0 -12,000 -50% $0.000000 12,000 13 May 2023 Common Stock 12,000 Direct F1
transaction INO Common Stock Options Award $0 +35,000 $0.000000 35,000 15 May 2023 Common Stock 35,000 $0.7700 Direct F3, F4
transaction INO Restricted Stock Unit Award $0 +26,000 $0.000000 26,000 15 May 2023 Common Stock 26,000 Direct F3, F5
transaction INO Restricted Stock Unit Options Exercise $0 -19,000 -100% $0.000000* 0 16 May 2023 Common Stock 19,000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 36,000 restricted stock units is as follows: 12,000 shares vested on May 13, 2022; 12,000 shares vested on May 13, 2023; 12,000 shares will vest on May 13, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.
F3 This grant was made under the 2016 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy.
F4 Options to vest 100% on May 15, 2024.
F5 Each restricted stock unit represents a contingent right to receive one share of common stock. The restricted stock units will vest 100% on May 15, 2024.